Gilead Sciences Inc (GILD)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 28,749,000 | 28,295,000 | 27,800,000 | 27,450,000 | 27,116,000 | 27,390,000 | 27,382,000 | 27,043,000 | 27,281,000 | 27,136,000 | 27,515,000 | 27,472,000 | 27,305,000 | 27,482,000 | 26,638,000 | 25,564,000 | 24,689,000 | 23,147,000 | 22,174,000 | 22,716,000 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $28,749,000K ÷ $—K
= —
The receivables turnover ratio for Gilead Sciences Inc is not provided in the data provided. Therefore, we are unable to calculate or analyze the company's receivables turnover for the periods mentioned. Receivables turnover ratio measures how efficiently a company is able to collect payments from its customers for the goods or services it has provided. A higher receivables turnover ratio indicates a faster turnover of receivables, which can be a positive signal of strong liquidity and efficient management of accounts receivable. Conversely, a low receivables turnover ratio may signify potential issues with collection processes or credit policies. Additionally, fluctuations in the receivables turnover ratio over time can provide insights into changes in the company's sales and collection practices.
Peer comparison
Dec 31, 2024